Top Markets
#1 TENDIES TENDIES +22.00%
#2 Helium Helium +18.46%
#3 Pons Pons +17.91%
#4 Songbird Songbird +11.38%
#5 OSK OSK +9.78%
#6 MarsCoin MarsCoin +9.53%
#7 Biconomy Biconomy +9.26%
#8 pipedog pipedog +8.20%
#9 Seeker Seeker +7.91%
#10 Lista DAO Lista DAO +7.42%
Coin of the day
TENDIES TENDIES
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Chongqing Lummy Pharmaceutical Co., Ltd. Chongqing Lummy Pharmaceutical Co., Ltd.

Chongqing Lummy Pharmaceutical Co., Ltd.

300006
Rangering i aksjer #10090
Chongqing Lummy Pharmaceutical Co., Ltd. is a Chinese firm dedicated to the... Chongqing Lummy Pharmaceutical Co., Ltd. is a Chinese firm dedicated to the research, development, production, and distribution of a broad spectrum of pharmaceutical products. Its extensive portfolio encompasses treatments for various therapeutic areas, including oncology, infectious diseases (antibacterial, antiviral, and antifungal), liver support, and endocrine disorders. The company also develops and markets medications for the digestive, immune, blood, cardiovascular, and nervous systems, in addition to traditional Chinese patent medicines. Further offerings include electrolyte and acid-base balancing agents, nutritional supplements, large volume parenteral solutions, American ginseng preparations, and active pharmaceutical ingredients. Established in 1999, the company's headquarters are located in Chongqing, China.
Aksjekurs
$0.84484795
Sist synkronisert: 2026-08-28
Markedsverdi
$892.08M
Endring (1 dag)
-4.11%
Endring (1 år)
27.37%
Land
CN
Handel Chongqing Lummy Pharmaceutical Co., Ltd. (300006)

Kategori

Healthcare
Inntekter for Chongqing Lummy Pharmaceutical Co., Ltd. (300006)
Inntekter i 2026 TTM: 0
Ifølge Chongqing Lummy Pharmaceutical Co., Ltd. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Chongqing Lummy Pharmaceutical Co., Ltd. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
$33.59B -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
$25.20B -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
$8.70B -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
$21.39B -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
$5.95B -
US